Figure 2.
Proportion of seroconversion in patients: seroprevalence proportions in (A) all early breast cancer patients, (B) with cytotoxic chemotherapy treatments, (C) with non-cytotoxic treatments, and (D) without anti-cancer treatment.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.